COVID-19 strained colorectal cancer screening workflows at a Los Angeles FQHC
The early months of COVID-19 hit colorectal cancer screening at a federally qualified health center with unusual force. Routine visits stalled, staff were pulled toward patients with upper respiratory illness, and the systems needed to keep screening moving were not built for a prolonged public health emergency. In this setting, colorectal cancer screening became one more service competing for attention inside an overburdened safety-net clinic rather than a stable preventive program with predictable workflows.
Interviews with clinic leadership and frontline staff at a Los Angeles-based FQHC captured how screening delivery changed across three phases of the pandemic: early in 2020, later in 2020, and through 2021. The qualitative work relied on hour-long telephone interviews, recorded and transcribed for content analysis by trained methodologists. Twenty participants took part, with ages ranging from 26 to 56 years. Most were women, and most held leadership roles, giving the analysis a view from both operational oversight and day-to-day implementation.
Early disruption was severe. Clinic teams were dealing with a surge of infectious respiratory complaints, which reduced the attention and capacity available for preventive care. Telehealth had not yet been scaled quickly enough to absorb the loss of in-person visits, so outreach and screening could not simply shift from one channel to another. Disaster plans built for short, discrete events such as seasonal influenza offered little help when the pandemic persisted month after month.
One practical bottleneck was simple supply and access. Stool test kits were not always available in the quantities needed, and gastroenterology capacity was reduced, leaving fewer downstream options when abnormal screening results required colonoscopy follow-up. Screening programs can tolerate a temporary slowdown, but they become fragile when every link in the chain weakens at once: outreach, specimen distribution, test processing, specialty referral, and procedure access all have to function for prevention to work.
Staffing instability and the erosion of outreach capacity
The pandemic did not just interrupt patient visits. It also destabilized the workforce needed to keep screening on the agenda. Hiring and retaining staff for cancer screening outreach remained difficult throughout the pandemic, creating a persistent drain on the clinic’s ability to track eligible patients, contact them, and close screening gaps. In a safety-net setting, outreach staff often serve as the connective tissue between primary care, laboratory testing, and specialty referral; when that layer thins, screening rates can slip even if clinicians continue to recommend testing.
The problem was not limited to personnel counts. Screening outreach depends on familiarity with clinic workflows, accurate use of health records, and repetition over time. When staff turnover is high, each new hire must relearn processes that are often invisible until they fail. For colorectal cancer prevention, a missed call, a delayed mailing, or a broken referral can leave an abnormal result unresolved for months.
Later adaptations restored some screening momentum
By the later phase of the pandemic, the FQHC had begun to adapt. Leaders expanded the available screening options, introduced health record tools that enabled automated outreach, and retrained staff on screening workflows. Those changes mattered because they reduced reliance on one-off manual tasks and made outreach more systematic. Automation cannot replace clinical judgment, but it can preserve continuity when staffing is unstable and the clinic is managing competing demands.
The shift toward more home-based testing also fits the biology and logistics of colorectal cancer prevention. Stool-based tests offer a route to screening that does not depend on transportation, procedure scheduling, or endoscopy suite availability. In a pandemic, when patients may avoid in-person care and specialty services may be constrained, home testing gives primary care teams a way to keep detection efforts alive without asking patients to navigate multiple disrupted systems.
A single care pathway was no longer enough.
Disaster planning for prevention cannot stop at acute care response
Interviewees pointed to several strategies that could strengthen preparedness for future pandemics or other disasters. One was better monitoring of infectious disease trends through incoming patient call data so staffing decisions could shift earlier in response to changing demand. Another was diversifying vendor relationships and specialty partnerships, especially for gastroenterology, so a single disruption would not sever access to follow-up care. Expanded home-based testing was also seen as a practical way to preserve screening when face-to-face services are strained.
These recommendations have clear relevance for federally qualified health centers, where staffing, funding, and specialty access are often already tight even before a crisis begins. Preventive cancer screening depends on a coordinated delivery model, but emergency planning in many clinics has traditionally centered on short-lived events. COVID-19 exposed the weakness of that assumption. A health center preparing only for a brief surge in flu-like illness will not be ready for a prolonged breakdown in routine care.
The study also reinforces an important operational point: screening programs are not isolated projects, but living systems embedded in primary care. When telehealth infrastructure is limited, when stool kits run short, and when specialty care capacity contracts, the result is not just inconvenience. It is a measurable threat to cancer prevention, especially in communities served by safety-net institutions.
What this single-center experience can and cannot tell clinicians
This work offers a detailed account of how one large FQHC in Los Angeles responded to pandemic-era disruption, but the findings come from a single site and should not be generalized without caution. Even so, the account is clinically useful because it shows where colorectal cancer screening broke down and which fixes were practical enough to implement during an ongoing emergency.
The most useful lesson is operational rather than abstract: screening survives crises when clinics can pivot quickly, maintain specimen access, preserve specialty referral pathways, and keep outreach tied to real-time patient demand. For FQHCs, that may mean building disaster plans that treat preventive care as essential rather than optional, and designing systems that can continue even when routine visits, staffing patterns, and referral networks are all under stress.